Publications

Journal Article Ppublish 1453 citations
Electronic publication date
March 10, 1995

View on Pubmed.gov 7878466 | View on doi.org 10.1126/science...

Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation.

Search for publications in this journal Science - 267(5203):1485-8

Abstract

I kappa B-alpha inhibits transcription factor NF-kappa B by retaining it in the cytoplasm. Various stimuli, typically those associated with stress or pathogens, rapidly inactivate I kappa B-alpha. This liberates NF-kappa B to translocate to the nucleus and initiate transcription of genes important for the defense of the organism. Activation of NF-kappa B correlates with phosphorylation of I kappa B-alpha and requires the proteolysis of this inhibitor. When either serine-32 or serine-36 of I kappa B-alpha was mutated, the protein did not undergo signal-induced phosphorylation or degradation, and NF-kappa B could not be activated. These results suggest that phosphorylation at one or both of these residues is critical for activation of NF-kappa B.

References

No references provided.

Cited by 1453 citations (total)

Journal Article

RSK3 switches cell fate: from stress-induced senescence to malignant progression.

Electronic publication date November 28, 2023

Search for publications in this journal J Exp Clin Cancer Res

Anda Huna [...] David Bernard et al.

BACKGROUND

TGFβ induces several cell phenotypes including senescence, a stable cell cycle arrest accompanied by a secretory program, and epithelial-mesenchymal transition...

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Distinct domains of IkappaBalpha regulate c-Rel in the cytoplasm and in the nucleus.

Electronic publication date March 6, 1998

Search for publications in this journal Mol Cell Biol

I Luque [...] C Gélinas et al.

IkappaBalpha is a critical regulator of Rel/NF-KB-mediated gene activation. It controls the induction of NF-KB factors by retaining them in...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Substances